Literature DB >> 14985261

Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry.

Stefan J Teipel1, Gene E Alexander, Marc B Schapiro, Hans-Jürgen Möller, Stanley I Rapoport, Harald Hampel.   

Abstract

Ageing in Down's syndrome is accompanied by amyloid and neurofibrillary pathology the distribution of which replicates pathological features of Alzheimer's disease. With advancing age, an increasing proportion of Down's syndrome subjects >40 years old develop progressive cognitive impairment, resembling the cognitive profile of Alzheimer's disease. Based on these findings, Down's syndrome has been proposed as a model to study the predementia stages of Alzheimer's disease. Using an interactive anatomical segmentation technique and volume-of-interest measurements of MRI, we showed recently that non-demented Down's syndrome adults had significantly reduced hippocampus, entorhinal cortex and corpus callosum sizes with increasing age. In this study, we applied the automated and objective technique of voxel-based morphometry, implemented in SPM99, to the analysis of structural MRI from 27 non-demented Down's syndrome adults (mean age 41.1 years, 15 female). Regional grey matter volume was decreased with advancing age in bilateral parietal cortex (mainly the precuneus and inferior parietal lobule), bilateral frontal cortex with left side predominance (mainly middle frontal gyrus), left occipital cortex (mainly lingual cortex), right precentral and left postcentral gyrus, left transverse temporal gyrus, and right parahippocampal gyrus. The reductions were unrelated to gender, intracranial volume or general cognitive function. Grey matter volume was relatively preserved in subcortical nuclei, periventricular regions, the basal surface of the brain (bilateral orbitofrontal and anterior temporal) and the anterior cingulate gyrus. Our findings suggest grey matter reductions in allocortex and association neocortex in the predementia stage of Down's syndrome. The most likely substrate of these changes is alterations or loss of allocortical and neocortical neurons due to Alzheimer's disease-type pathology.

Entities:  

Mesh:

Year:  2004        PMID: 14985261     DOI: 10.1093/brain/awh101

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  58 in total

1.  Gait adaptations in response to perturbations in adults with Down syndrome.

Authors:  Beth A Smith; James A Ashton-Miller; Beverly D Ulrich
Journal:  Gait Posture       Date:  2010-05-07       Impact factor: 2.840

2.  Education-associated cortical glucose metabolism during sustained attention.

Authors:  Daniel P Eisenberg; Edythe D London; John A Matochik; Stuart Derbyshire; Lisa J Cohen; Matthew Steinfeld; James Prosser; Igor I Galynker
Journal:  Neuroreport       Date:  2005-09-08       Impact factor: 1.837

3.  Anatomic correlates of stereotypies in frontotemporal lobar degeneration.

Authors:  Keith A Josephs; Jennifer L Whitwell; Clifford R Jack
Journal:  Neurobiol Aging       Date:  2007-06-14       Impact factor: 4.673

4.  Neuroimaging of individuals with Down's syndrome at-risk for dementia: evidence for possible compensatory events.

Authors:  R J Haier; K Head; E Head; I T Lott
Journal:  Neuroimage       Date:  2007-10-12       Impact factor: 6.556

5.  Complexity of force output during static exercise in individuals with Down syndrome.

Authors:  Kevin S Heffernan; Jacob J Sosnoff; Edward Ofori; Sae Young Jae; Tracy Baynard; Scott R Collier; Stella Goulopoulou; Arturo Figueroa; Jeffrey A Woods; Kenneth H Pitetti; Bo Fernhall
Journal:  J Appl Physiol (1985)       Date:  2009-01-22

6.  Corpus callosal area differences and gender dimorphism in neuroleptic-naïve, recent-onset schizophrenia and healthy control subjects.

Authors:  John P John; Mohammed Kalathil Shakeel; Sanjeev Jain
Journal:  Schizophr Res       Date:  2008-06-26       Impact factor: 4.939

Review 7.  Biological markers of amyloid beta-related mechanisms in Alzheimer's disease.

Authors:  Harald Hampel; Yong Shen; Dominic M Walsh; Paul Aisen; Les M Shaw; Henrik Zetterberg; John Q Trojanowski; Kaj Blennow
Journal:  Exp Neurol       Date:  2009-10-06       Impact factor: 5.330

8.  Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia.

Authors:  Marwan N Sabbagh; Kewei Chen; Joseph Rogers; Adam S Fleisher; Carolyn Liebsack; Dan Bandy; Christine Belden; Hillary Protas; Pradeep Thiyyagura; Xiaofen Liu; Auttawut Roontiva; Ji Luo; Sandra Jacobson; Michael Malek-Ahmadi; Jessica Powell; Eric M Reiman
Journal:  Alzheimers Dement       Date:  2015-04-04       Impact factor: 21.566

9.  Frontal white matter integrity in adults with Down syndrome with and without dementia.

Authors:  David Powell; Allison Caban-Holt; Gregory Jicha; William Robertson; Roberta Davis; Brian T Gold; Frederick A Schmitt; Elizabeth Head
Journal:  Neurobiol Aging       Date:  2014-02-04       Impact factor: 4.673

Review 10.  Novel MRI techniques in the assessment of dementia.

Authors:  Stefan J Teipel; Thomas Meindl; Lea Grinberg; Helmut Heinsen; Harald Hampel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.